Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2006-12-18
2010-10-26
Davis, Ruth A (Department: 1651)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S400000
Reexamination Certificate
active
07820195
ABSTRACT:
The invention provides micronized encapsulated cell therapy devices that are capable of delivering a biologically active molecule to the eye. Also provided are methods of using the same to deliver biologically active molecules to the eye and to treat ophthalmic disorders in patients suffering there from.
REFERENCES:
patent: 3615024 (1971-10-01), Michaels
patent: 4352833 (1982-10-01), Young et al.
patent: 4409331 (1983-10-01), Lim
patent: 4744933 (1988-05-01), Rha et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4968733 (1990-11-01), Müller et al.
patent: 4976859 (1990-12-01), Wechs
patent: 5002661 (1991-03-01), Chick et al.
patent: 5049493 (1991-09-01), Khosla et al.
patent: 5082670 (1992-01-01), Gage et al.
patent: 5156844 (1992-10-01), Aebischer et al.
patent: 5158881 (1992-10-01), Aebischer et al.
patent: 5167762 (1992-12-01), Carr et al.
patent: 5283187 (1994-02-01), Aebischer et al.
patent: 5284761 (1994-02-01), Aebischer et al.
patent: 5512600 (1996-04-01), Mikos et al.
patent: 5550050 (1996-08-01), Holland et al.
patent: 5639275 (1997-06-01), Baetge et al.
patent: 5653688 (1997-08-01), Mills et al.
patent: 5653975 (1997-08-01), Baetge et al.
patent: 5713887 (1998-02-01), Mills et al.
patent: 5738673 (1998-04-01), Mills et al.
patent: 5762798 (1998-06-01), Wenthold et al.
patent: 5932460 (1999-08-01), Mills et al.
patent: 6123700 (2000-09-01), Mills et al.
patent: 6303136 (2001-10-01), Li et al.
patent: 6361771 (2002-03-01), Tao et al.
patent: 6627422 (2003-09-01), Li et al.
patent: 6653687 (2003-11-01), Yamazaki
patent: 2005/0089960 (2005-04-01), Wahlberg et al.
patent: 2005/0180957 (2005-08-01), Scharp et al.
patent: 2005/0287320 (2005-12-01), Dalton et al.
patent: WO 91/00119 (1991-01-01), None
patent: WO 92/03327 (1992-05-01), None
patent: WO 92/19195 (1992-11-01), None
patent: WO 93/00128 (1993-01-01), None
patent: WO 93/03901 (1993-03-01), None
patent: WO 95/05452 (1995-02-01), None
patent: WO 97/34586 (1997-09-01), None
patent: WO 98/43177 (1998-10-01), None
patent: WO 99/52573 (1999-10-01), None
Baetge et al., “Transgenic mice express the human phenylethanolamine N-methyltransferase gene in adrenal medulla and retina”,Proc. Natl. Acad. Sci. USA,85:3648-3652 (1988).
Besnard et al., “Multiple Interacting Sites Regulate Astrocyte-specific Transcription of the Human Gene for Glial Fibrillary Acidic Protein”J. Biol. Hem.,266(28):18877-18883 (1991).
Cepko, C.L., “Retrovirus Vectors and Their Applications in Neurobiology”Neuron,1:345-353 (1988).
Chick et al., “A transplantable insulinoma in the rat”Proc. Natl. Acad. Sci. USA,74:628-632 (1977).
Christenson et al., “Tissue reaction to intraperitoneal polymer implants: Species difference and effects of corticoid and doxorubicin”J. Biomed. Mat. Res.,23:705-718 (1989).
Christenson, L., “Polymer-encapsulated thymic stromal tissue: Biocompatibility, procurement and functional studies” Dissertation, Brown University, pp. 1-119 (1990).
Colton, “Engineering challenges in cell-encapsulation technology”Trends Biotechnol.,14:158-162 (1996).
Dirks et al., “Dicistronic transcription units for gene expression in mammalian cells”Gene,128:247-249 (1993).
Dunn et al., “ARPE-19, A Human Retinal Pigment Epithelial Cell Line with Differentiation Properties”Exp. Eye Res.,62:155-169 (1996).
Dunn et al., ,,Use of the ARPE-19 Cell Line as a Model of RPE Polarity: Basolateral Secretion of FGF5Invest. Ophthalmol. Vis. Sci.,39:2744-2749 (1998).
Faithful, N.S., “Fluorocarbons”Anaesthesia,42:234-242 (1987).
Finnemann et al., “Phagocytosis of rod outer segments by retinal pigment epithelial cells requires αvβ5 integrin for binding but not for internalization”Proc. Natl. Acad. Sci. USA,94:12932-12937 (1997).
Gale Group Newsletter DB™, “Regeneron's Neurotrophic Factors Prevent Degeneration of Eye Retina Cells”Genetic Technology News,vol. 13, No. 1, 2 pages (1993).
Hamaguchi et al., “NIT-1, a Pancreatic β-Cell Line Established From a Transgenic NOD/Lt Mouse”Diabetes,40:842-849 (1991).
Handa et al., “The Advanced Glycation Endproduct Pentosidine Induces the Expression of PDGF-B in Human Retinal Pigment Epithelial Cells”Exp. Eye Res.,66:411-419 (1998).
Holtkamp et al., “Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells”Clin. Exp. Immunol.,112:34-43 (1998).
Hughes et al., “Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells”Proc. Natl. Acad. Sci. USA,89:688-692 (1992).
Kaneda et al., “Tissue-Specific and High-Level Expression of the Human Tyrosine Hydroxylase Gene in Transgenic Mice”Neuron,6:583-594 (1991).
Land et al., “Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncognenes”Nature,304:596-602 (1983).
Lemke et al., “Isolation and Analysis of the Gene Encoding Peripheral Myelin Protein Zero”Neuron,1:73-83 (1988).
Lim et al., “Microencapsulated Islets as Bioartificial Endocrine Pancreas”Science,210:908-910 (1980).
Lysaght et al., “Recent Progress in Immunoisolated Cell Therapy”J. Cell. Biochem.,56:196-203 (1996).
Macejak, “Internal initiation of translation mediated by the 5′ leader of a cellular mRNA”Nature,353:90-94 (1991).
Maidji et al., “Accessory Human Cytomegalovirus Glycoprotein US9 in the Unique Short Component of the Viral Geome Promotes Cell-to-Cell Transmission of Virus in Polarized Epithelial Cells”J. Virol.,70:8402-8410 (1996).
Martinez-Salas et al., “A Single Nucleotide Substitution in the Internal Ribosome Entry Site of Foot-and-Mouth Disease Virus Leads to Enhanced Cap-Independent Translation In Vivo”.,J. Virol.,67:3748-3755 (1993).
Matsumoto et al., “Human macrophage scavenger receptors: Primary structure, expression, and localization in atherosclerotic lesions”Proc. Natl. Acad. Sci. USA,87:9133-9137 (1990).
Mercer et al., “The Dopamine β-Hydroxylase Gene Promoter Directs Expression ofE. coli lacZto Sympathetic and other Neurons in Adult Transgenic Mice”Neuron,7:703-716 (1991).
Mountford et al., “Dicistronic targeting constructs: Reporters and modifiers of mammalian gene expression”Proc. Natl. Acad. Sci. USA,91:4303-4307 (1994).
Mountford et al., “Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis”Trends Genet.,11:179-184 (1995).
Nakahira et al., “Structure of the 68-kDa Neurofilament Gene and Regulation of Its Expression”J. Biol. Hem.,265:19786-19791 (1990).
NASA Tech. Briefs,“Emulsions Containing Perfluorocarbon Support Cell Cultures” MSC-21480, Technical Support Package, U.S. Government Printing Office, Washington, D.C. 5 pages.
NASA Tech. Briefs,“Cloned Hemoglobin Genes Enhance Growth of Cells” NPO-17517/7027, Technical Support Package, Khosla and Bailey (inventors), vol. 15, No. 1, Item #113, pp. 54, 1, 1a, 1b-29b (1991).
Rajotte et al., “Optimizing Cryopreservation of Isolated Islets”Transplantation Proceedings,21(1):2638-2640 (1989).
Ray et al., “Proliferation, differentiation, and long-term culture of primary hippocampal neurons”Proc. Natl. Acad. Sci. USA,90:3602-3606 (1993).
Richards et al., “De novo generation of neuronal cells from the adult mouse brain”Proc. Natl. Acad. Sci. USA,89:8591-8595 (1992).
Sakimura et al., “The structure and expression of neuron-specific enolase gene”Gene,60:103-113 (1987).
Scharp et al., “Islet Immuno-isolation: The Use of Hybrid Artificial Organs to Prevent Islet Tissue Rejection”World J. Surg.,8:221-229 (1984).
Siliprandi et al., “Nerve Growth Factor Promotes Functional Recovery of Retinal Ganglion Cells After Ischemia”Invest. Ophthalmol. Vis. Sci.,34:3232-3245 (1993).
Southern, P.J., “Mammalian Cel
Kauper Konrad
Stabila Paul
Tao Weng
Davis Ruth A
Elrifi, Esq. Ivor R.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Neurotech USA, Inc.
Stock, Esq. Christina K.
LandOfFree
Micronized device for the delivery of biologically active... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Micronized device for the delivery of biologically active..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Micronized device for the delivery of biologically active... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4183729